Table 1

Patient Characteristics

Overall
(n = 995)
Nonsurvivors
(n = 412)
Survivors
(n = 583)
p Value
Age, yrs
 <65220 (22)66 (70)154 (30)<0.001
 65–79527 (53)221 (58)306 (42)
 ≥80248 (25)125 (50)123 (50)
Female335 (34)140 (34)195 (33)0.86
BMI, kg/m2
 ≥20.0647 (65)221 (34)426 (66)<0.001
 18.0–19.9213 (21)106 (50)107 (50)
 <18.0135 (14)85 (63)50 (37)
Ambulatory560 (56)156 (38)404 (69)<0.001
Hypertension745 (75)304 (74)441 (76)0.51
Dyslipidemia380 (38)129 (31)251 (43)<0.001
Diabetes695 (70)279 (68)416 (71)0.22
Hemodialysis587 (59)282 (68)305 (52)<0.001
Current smoker300 (30)116 (28)184 (32)0.25
Cerebrovascular disease272 (27)140 (34)132 (23)<0.001
Coronary artery disease541 (54)230 (56)311 (53)0.44
LVEF, %
 ≥50739 (74)263 (36)476 (64)<0.001
 40–49134 (13)73 (54)61 (46)
 <40120 (12)75 (63)45 (38)
Rutherford class
 4245 (25)58 (14)187 (32)<0.001
 5505 (51)211 (51)294 (50)
 6245 (25)143 (35)102 (17)
Tissue loss750 (75)354 (86)396 (68)<0.001
Medication
 Aspirin784 (79)334 (81)450 (77)0.14
 Thienopyridine385 (39)151 (37)234 (40)0.27
 Cilostazol498 (50)196 (48)302 (52)0.19
 Statin224 (23)74 (18)150 (26)0.004
 Beta-blocker169 (20)81 (22)88 (18)0.12
 Anticoagulant agent197 (20)91 (22)106 (18)0.13

Values are n (%).

BMI = body mass index; LVEF = left ventricular ejection fraction.